Literature DB >> 24385645

Integrated screening for tuberculosis and HIV in tuberculosis contact investigations: lessons learned in North Carolina.

Jason E Stout1, Shereen Katrak2, Neela D Goswami3, Brianna L Norton3, Ellen R Fortenberry4, Evelyn Foust5, Peter A Leone6.   

Abstract

Combating the syndemics of tuberculosis (TB) and HIV in the United States will require increasing efficiency as the incidence of TB declines. Fortunately, new tools such as the interferon gamma release assays can be combined with existing strategies such as opt-out HIV testing to facilitate simultaneous, integrated testing for both infections. We describe the lessons learned from our experience with integrated testing for TB and HIV in the setting of TB contact investigations in North Carolina. Integrated testing represents a unique opportunity to leverage TB and HIV program resources to enhance case detection and improve linkages to care. However, joint training in field investigations and diagnostics is critical prior to conducting contact investigations. Furthermore, integrated testing must be tightly coupled to treatment and prevention programs to reduce disease transmission and morbidity from untreated disease in communities.

Entities:  

Mesh:

Year:  2014        PMID: 24385645      PMCID: PMC3862984          DOI: 10.1177/00333549141291S104

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  15 in total

1.  Priorities for screening and treatment of latent tuberculosis infection in the United States.

Authors:  Benjamin P Linas; Angela Y Wong; Kenneth A Freedberg; C Robert Horsburgh
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

2.  Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

Authors:  Gerald H Mazurek; John Jereb; Andrew Vernon; Phillip LoBue; Stefan Goldberg; Kenneth Castro
Journal:  MMWR Recomm Rep       Date:  2010-06-25

3.  Pairing QuantiFERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern United States.

Authors:  Anna K Person; Neela D Goswami; Deborah J Bissette; Debra S Turner; Ann V Baker; L Beth Gadkowski; Susanna Naggie; Kirby Erlandson; Luke Chen; Tahaniyat Lalani; Gary M Cox; Jason E Stout
Journal:  AIDS Patient Care STDS       Date:  2010-09       Impact factor: 5.078

4.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

5.  Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary tuberculosis: feasibility and costs.

Authors:  Jiehui Li; Suzanne M Marks; Cynthia R Driver; Francisco A Diaz; Alejandro F Castro; Annette Figueroa de Regner; Aurelia E Gibson; Kinta Dokubo-Okereke; Sonal S Munsiff
Journal:  J Public Health Manag Pract       Date:  2007 May-Jun

6.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

7.  Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2005-12-16

8.  Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Authors:  Gillian D Sanders; Ahmed M Bayoumi; Vandana Sundaram; S Pinar Bilir; Christopher P Neukermans; Chara E Rydzak; Lena R Douglass; Laura C Lazzeroni; Mark Holodniy; Douglas K Owens
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

9.  Results of testing for human immunodeficiency virus infection among recent contacts of infectious tuberculosis cases in the United States.

Authors:  M R Reichler; S Bur; R Reves; B Mangura; V Thompson; J Ford; K G Castro
Journal:  Int J Tuberc Lung Dis       Date:  2003-12       Impact factor: 2.373

10.  Geographic information system-based screening for TB, HIV, and syphilis (GIS-THIS): a cross-sectional study.

Authors:  Neela D Goswami; Emily J Hecker; Carter Vickery; Marshall A Ahearn; Gary M Cox; David P Holland; Susanna Naggie; Carla Piedrahita; Ann Mosher; Yvonne Torres; Brianna L Norton; Sujit Suchindran; Paul H Park; Debbie Turner; Jason E Stout
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

View more
  2 in total

1.  Program collaboration and service integration in the prevention and control of HIV infection, viral hepatitis, STDs, and tuberculosis in the U.S.: lessons learned from the field.

Authors:  Kevin A Fenton; Gustavo A Aquino; Hazel D Dean
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

2.  Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers.

Authors:  Carolina de la Flor; Esmaeil Porsa; Ank E Nijhawan
Journal:  Public Health Rep       Date:  2017-10-18       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.